Let’s hope they lose big time
Providing some context:
Due to the American Healthcare System barely doing anything to cap prices for medication, it is VERY profitable selling that stuff there.
Tarifs would massively reduce profit for pharma companies, so they consider leaving other places for the one market where then can do the most exploitation, which is America. Moving the production there is just a way to dodge tarifs.
It will probably backfire with the whole political and societal instability looming, but companies are blind on that eye.
Trump is also rolling back environmental protections. And pharma companies just love to be able to dump their sewage into the next river and in the process create more patients for themselves. (There are documentaries about Indian towns downriver from pharma factories where half the children are stunted asthmatic epileptics.)
There are documentaries about Indian towns downriver from pharma factories where half the children are stunted asthmatic epileptics
You forgot about the fact that its India. People are dumping everything in the rivers like plastics, trash, ashes or defecating there. And there isn’t any river that is not contaminated there. So pharma companies dumping their sewage would be the least of a concern imo.
Not forgetting that it’s India. Just saying that Trump is making the US more like India (again).
Are they fans of Trump or what?
Much of it seems to be regular upkeep of existing facilities. They’re the 3rd largest pharma company in the world, so they have a sizeable presence almost everywhere already. This seems just like PR for things that have likely been planned long before now.
From Roche’s Press Release:
As part of this investment, Roche will increase its existing footprint of more than 25,000 employees in 24 sites across eight US states. The investment will include:
-Expanded and upgraded US manufacturing and distribution capabilities for its innovative medicines and diagnostics portfolio in Kentucky, Indiana, New Jersey, Oregon and California
-A state-of-the-art gene therapy manufacturing facility in Pennsylvania
-A new 900,000 square foot manufacturing centre to support Roche’s expanding portfolio of next generation weight loss medicines (location to be announced)
-A new manufacturing facility for continuous glucose monitoring in Indiana
-A new R&D centre in Massachusetts, conducting cutting-edge artificial intelligence (AI) research and serving as hub for our new cardiovascular, renal and metabolism research and development efforts
-Significant expansion and upgrading of our existing pharmaceuticals and diagnostics R&D centres in Arizona, Indiana and California
Roche is a Swiss company with a strong heritage in more than 130 countries globally.
We are proud of our 110 year legacy in the United States.
